Good point. Everyone knows this is undervalued compared with its $1.15 IPO and $18m in cash.
Even though it may be ~18 months away for FDA completion, there will likely be various news and updates as catalysts, along with sales of its recent TGA approved product.
Looks to me like a company turnaround point, but time will tell.
The good news is when it moves, it can move quick!
Tissue Repair: Hidden Gem in Biotech!, page-127
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $27.81M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.5¢ | 43.5¢ | $60.06K | 131.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111925 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 31148 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| TRP (ASX) Chart |